Looking ahead, the industry needs to find a framework for challenging the government on its decision-making and our recognition of the bad, the ugly and the very good in 2023.
Latest Video
New Stories
-
Amplia enters into preclinical collaboration with Korean drug screening company
November 14, 2024 - - Australian Biotech -
Botanix expands US payer coverage for Sofdra with Ascent Health agreement
November 14, 2024 - - Australian Biotech -
MA proposes CEO for HTA Review implementation group and wants 'continuity'
November 14, 2024 - - Latest News -
Any approach to government relations based on the Montessori method is doomed to fail
November 14, 2024 - - Latest News -
AusBiotech announces the Inaugural Depaz Oration
November 14, 2024 - - Latest News -
Data shows invasive pneumococcal disease at highest level in 15 years
November 13, 2024 - - Latest News -
Arthritis experts launch the ATLAS arthritis eLearning program for health professionals
November 13, 2024 - - Latest News